How CGM Use in Adults With Type 2 Diabetes Leads to Glycemic Benefits: The Role of Medication and Behaviour Change.
Saved in:
| Title: | How CGM Use in Adults With Type 2 Diabetes Leads to Glycemic Benefits: The Role of Medication and Behaviour Change. |
|---|---|
| Authors: | Polonsky WH; Behavioral Diabetes Institute, San Diego, California, USA., Clark TL; Behavioral Diabetes Institute, San Diego, California, USA., Soriano EC; Scripps Whittier Diabetes Institute, Scripps Health, La Jolla, California, USA., Edgington A; Hancock Public Health, Findlay, Ohio, USA., Bennett CM; Blanchard Valley Health System, Findlay, Ohio, USA., Fox AE; Blanchard Valley Health System, Findlay, Ohio, USA., Grace T; Dexcom, San Diego, California, USA. |
| Source: | Endocrinology, diabetes & metabolism [Endocrinol Diabetes Metab] 2026 May; Vol. 9 (3), pp. e70236. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101732442 Publication Model: Print Cited Medium: Internet ISSN: 2398-9238 (Electronic) Linking ISSN: 23989238 NLM ISO Abbreviation: Endocrinol Diabetes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2398-9238 |
|---|---|
| DOI: | 10.1002/edm2.70236 |
